A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada

A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada

This study models the impact of using two different types of high-risk (HR) human papillomavirus (HPV) tests: mRNA (Aptima) and DNA (Hybrid Capture 2) as part of a hypothetical primary HPV screening program in Ontario, Canada. Outcomes were the costs of the screening program, and number of colposcop...

Full description

Bibliographic Details
Main Authors: Georgie Weston, Caroline Dombrowski, Marc Steben, Catherine Popadiuk, James Bentley, Elisabeth J. Adams
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Preventive Medicine Reports
Subjects:
HPV infection
Cancer screening
Economic model
Online Access:http://www.sciencedirect.com/science/article/pii/S2211335521001388

Internet

http://www.sciencedirect.com/science/article/pii/S2211335521001388

Similar Items